Stahl Stephen M
CNS Spectr. 2016 Feb;21(1):1-6. doi: 10.1017/S1092852915000954.
Brexpiprazole is a new therapeutic agent that was recently approved for the treatment of schizophrenia and for the adjunctive treatment of major depressive disorder. Brexpiprazole has features that both overlap and contrast with a related molecule, aripiprazole, and these features are discussed here.
布雷哌唑是一种新型治疗药物,最近被批准用于治疗精神分裂症以及作为重度抑郁症的辅助治疗药物。布雷哌唑具有与相关分子阿立哌唑重叠和对比的特征,本文将对这些特征进行讨论。